The Daily

The Trump administration announced the creation of a $1.8 billion fund to compensate those who claim they were targeted by the Biden Justice Department and Democrats.

Andrew Duehren, who covers tax policy, explains how the fund came about and who might get the money. 

Guest: Andrew Duehren, who writes about tax policy for The New York Times from Washington.

Background reading: 

The Justice Department announced the $1.8 billion fund on Monday.

Mr. Trump’s “anti-weaponization” fund, explained.

Photo: Eric Lee for The New York Times

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In Kentucky today, amid record-low approval ratings, President Trump is asking Republican primary voters to reject Representative Thomas Massie, who has broken with Mr. Trump on a handful of votes.

Instead, he wants them to elect his handpicked challenger.

Robert Draper, who covers domestic politics for The Times, and “The Daily” producer Caitlin O’Keefe, travel to Kentucky to cover what has become the most expensive House primary in American history.

Guest:

Robert Draper, a Washington, D.C.-based journalist for The New York Times.

Caitlin O’Keefe, an audio producer on “The Daily.”

Background reading: 

In Kentucky, fidelity to Mr. Trump is once again on the ballot.

Photo: Michael Swensen for The New York Times

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

For the last three weeks, a messy, dramatic battle has played out between two of the most powerful titans of tech in the world: Elon Musk and Sam Altman.

As jury deliberations begin today, the technology reporter Mike Isaac takes us inside the courtroom drama and explains how a corporate dispute got extremely personal.

Guest: Mike Isaac, a New York Times reporter based in the San Francisco Bay Area, covering tech companies and Silicon Valley.

Background reading: 

Inside the courtroom circus with Elon Musk and Sam Altman.

Musk lawyer’s question for Sam Altman on the stand: Are you trustworthy?

Photo: Manuel Orbegozo/Reuters, Benjamin Fanjoy/Getty Images

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The quest for a “cure” for aging — a way to remain youthful, even as we get older — is a project as old as humanity. It’s also a big business; products, therapies and treatments intended to moderate or reverse aging are part of a $2 trillion global wellness market that’s only getting bigger.

But there have been some recent breakthroughs in the science of longevity that could be pivotal for the field. These discoveries have to do with cellular rejuvenation, which is the idea that scientists could take a cell that has aged, and make it function like a younger version of itself.

On this episode of “The Sunday Daily,” the host Rachel Abrams talks with Susan Dominus, a staff writer at The New York Times Magazine, about this new research, the scientists behind it and who is funding this scientific quest for longer lives.

On Today’s Episode:

Susan Dominus is a staff writer at The New York Times Magazine.

Background Reading:

Longevity Science Is Overhyped. But This Research Really Could Change Humanity.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The presumptive Democratic Senate nominee from Maine on his controversies, contradictions and pitch for radical change.

Thoughts? Email us at [email protected]

Watch our show on YouTube: youtube.com/@TheInterviewPodcast

For transcripts and more, visit: nytimes.com/theinterview

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.